Sub-inhibitory fosmidomycin exposures elicits oxidative stress in Salmonella enterica serovar Typhimurium LT2. - Test2 - elhamkhani - TriplyDB

Sub-inhibitory fosmidomycin exposures elicits oxidative stress in Salmonella enterica serovar Typhimurium LT2.

Sub-inhibitory fosmidomycin exposures elicits oxidative stress in Salmonella enterica serovar Typhimurium LT2.

http://www.wikidata.org/entity/Q35153938

about

Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.Exploring bacterial outer membrane barrier to combat bad bugs.

P2860

Q37428599-9F02B6AF-A7B2-45E4-BF6B-A936C83174E8 Q41633774-B3B900E9-4B3F-4E2A-B1A1-69C346B78FEF

P2860

Sub-inhibitory fosmidomycin exposures elicits oxidative stress in Salmonella enterica serovar Typhimurium LT2.

http://www.wikidata.org/entity/Q35153938

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Sub-inhibitory fosmidomycin ex ...... erica serovar Typhimurium LT2.

@ast

Sub-inhibitory fosmidomycin ex ...... erica serovar Typhimurium LT2.

@en

type

label

Sub-inhibitory fosmidomycin ex ...... erica serovar Typhimurium LT2.

@ast

Sub-inhibitory fosmidomycin ex ...... erica serovar Typhimurium LT2.

@en

prefLabel

Sub-inhibitory fosmidomycin ex ...... erica serovar Typhimurium LT2.

@ast

Sub-inhibitory fosmidomycin ex ...... erica serovar Typhimurium LT2.

@en

P1433

Q35153938-90E9D8DC-1D4E-4DA7-ACDC-0291779F35C7

P1476

Q35153938-7E9696C8-7CEA-48FF-A445-0FD4016AA6C8

P2093

Q35153938-2BE8C32B-C5AB-4F1B-BBA0-81B92D3F408A

Q35153938-6DF848B6-3818-4B36-A47C-F6FDFE03B2F7

Q35153938-77675F21-EA60-495C-AF29-7E7F41EA86C7

Q35153938-811F005B-0396-4FDE-BBB2-FDF46256BAE7

Q35153938-81CF0A5A-7D75-47AC-B658-476E3EBD17B6

Q35153938-895602A4-8C4C-4D82-AE75-E457F1E4AF71

Q35153938-8CFC833F-F5E2-461D-AEF6-DE2B80D82468

Q35153938-A4618394-3DA3-4CBB-A51D-D3E341E5A6D3

Q35153938-B44577DA-EB11-4BB5-9126-5743B0A6ED7A

Q35153938-D9632EFA-A374-4407-9781-0A1548D4831D

P2860

Q35153938-01A95E46-FF4A-4273-BF58-5B5001CEEC1A

Q35153938-01A9DBB8-CE83-4CE7-815E-F526D9E0EE66

Q35153938-07EA0D3F-DFC5-49ED-BA87-C6A217672E5E

Q35153938-07FF8E03-6528-4384-A799-9DFD10AF6E4C

Q35153938-08A3E4FA-5989-4A25-9327-ECCE78FF21EC

Q35153938-0EC970A5-6253-4D1A-94D2-F1A7DBBBAB1D

Q35153938-1C9E4FA4-FFA2-4993-A610-91334E1DBC37

Q35153938-1D38C15F-3DAD-467A-8A8A-2CE299E2AA56

Q35153938-24865A52-38B4-4FCA-A7D4-4DCD18DB6280

Q35153938-26741B1B-853E-4B30-AC4D-1627A194C446

P304

Q35153938-81FBFB87-CA67-4D24-9435-E8B37202C64B

P31

Q35153938-B3F8E47B-9ADF-4D3D-87BB-2378653F8F96

P356

Q35153938-70D7C1EE-4BFE-4A34-AC22-4FC2C788A997

P407

Q35153938-4D9BA48A-3140-441B-B6B0-D22A6D50550F

P433

Q35153938-F1904626-C39D-42FF-A8E1-995E962208E8

P478

Q35153938-7754E489-A9CE-4227-9D3B-2DEDF2EAB7AF

P577

Q35153938-22232AF6-C0F5-491A-B952-F3703F45328B

P5875

Q35153938-D41A77EF-C33C-40E2-A79A-FBCA33DEBC37

P698

Q35153938-3D169669-FE64-486A-B506-AD443E29CA18

P921

Q35153938-B6E3289D-F0E9-469A-AA5C-D17F30560B81

P932

Q35153938-01D54E2D-AC3E-4179-A6CA-6CA61AFF3360

P356

JOURNAL.PONE.0095271

P1433

P1476

Sub-inhibitory fosmidomycin ex ...... erica serovar Typhimurium LT2.

@en

P2093

Andrew T Koppisch

http://www.w3.org/2001/XMLSchema#string

Charles A Testa

http://www.w3.org/2001/XMLSchema#string

David T Fox

http://www.w3.org/2001/XMLSchema#string

Emily K Cope

http://www.w3.org/2001/XMLSchema#string

Emily N Schmidt

http://www.w3.org/2001/XMLSchema#string

Hongzhao Tian

http://www.w3.org/2001/XMLSchema#string

Jeff G Leid

http://www.w3.org/2001/XMLSchema#string

Kellan B Finney

http://www.w3.org/2001/XMLSchema#string

Michael C Valentine

http://www.w3.org/2001/XMLSchema#string

Nicole V Warrington

http://www.w3.org/2001/XMLSchema#string

P2860

Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis

Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli

A 1-deoxy-D-xylulose 5-phosphate reductoisomerase catalyzing the formation of 2-C-methyl-D-erythritol 4-phosphate in an alternative nonmevalonate pathway for terpenoid biosynthesis

Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria

Swarming populations of Salmonella represent a unique physiological state coupled to multiple mechanisms of antibiotic resistance

Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs

A common mechanism of cellular death induced by bactericidal antibiotics

Five questions about non-mevalonate isoprenoid biosynthesis

Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis

Swarming of Pseudomonas aeruginosa is a complex adaptation leading to increased production of virulence factors and antibiotic resistance

P304

e95271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0095271

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261769903

http://www.w3.org/2001/XMLSchema#string

P698

24751777

http://www.w3.org/2001/XMLSchema#string

P921

Salmonella enterica

P932

3994034

http://www.w3.org/2001/XMLSchema#string